Novo Nordisk
NVO
#93
Rank
โ‚น19.244 T
Marketcap
โ‚น4,353
Share price
-1.41%
Change (1 day)
-12.44%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น2.000 Trillion, an increase over its 2024 earnings that were of โ‚น1.882 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T12.71%
2025 โ‚น2.000 T6.28%
2024 โ‚น1.882 T28.01%
2023 โ‚น1.470 T57.81%
2022 โ‚น931.77 B5.24%
2021 โ‚น885.41 B12.38%
2020 โ‚น787.85 B13.11%
2019 โ‚น696.55 B-3.45%
2018 โ‚น721.43 B1.88%
2017 โ‚น708.10 B4.3%
2016 โ‚น678.88 B10.32%
2015 โ‚น615.36 B7.47%
2014 โ‚น572.61 B3.4%
2013 โ‚น553.77 B19.09%
2012 โ‚น465.02 B15.58%
2011 โ‚น402.34 B16.58%
2010 โ‚น345.13 B25.66%
2009 โ‚น274.66 B10.68%
2008 โ‚น248.16 B55.82%
2007 โ‚น159.26 B7.02%
2006 โ‚น148.81 B19.05%
2005 โ‚น125.00 B10.55%
2004 โ‚น113.07 B
2002 โ‚น76.17 B-14.39%
2001 โ‚น88.97 B-52.82%
2000 โ‚น188.57 B250%
1999 โ‚น53.87 B31.21%
1998 โ‚น41.06 B34.31%
1997 โ‚น30.57 B11.46%
1996 โ‚น27.42 B9.03%
1995 โ‚น25.15 B-3.15%
1994 โ‚น25.97 B-0.67%
1993 โ‚น26.14 B45.38%
1992 โ‚น17.98 B-13.81%
1991 โ‚น20.86 B37.12%
1990 โ‚น15.21 B-0.79%
1989 โ‚น15.33 B26.2%
1988 โ‚น12.15 B24.97%
1987 โ‚น9.72 B-0.9%
1986 โ‚น9.81 B-7.78%
1985 โ‚น10.64 B24.87%
1984 โ‚น8.52 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.010 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.970 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น730.91 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น915.91 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA